82-year-old Dave Obelkevich prepares for his 50th New York City Marathon, while other runners use the race to overcome personal challenges.
FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.
S&P webinar explores reinsurance outlook, AI risks, and the need for disciplined AI adoption to capture benefits while managing risks.
82-year-old Dave Obelkevich prepares for his 50th New York City Marathon, while other runners use the race to overcome personal challenges.
FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.
S&P webinar explores reinsurance outlook, AI risks, and the need for disciplined AI adoption to capture benefits while managing risks.